South Dakota lawmakers are weighing the issue of a mother's privacy over her infant's health. The debate begins in the Senate Health and Human Services committee.
Senate Bill 105 authorizes healthcare practitioners to test infants up to 28 days old for controlled substances if they exhibit relevant symptoms. The bill allows the test with or without parental consent. If results are positive, the practitioner must report them to the Department of Social Services.